AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H901. A total of 4 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,097,504 | -3.4% | 278,400 | +13.8% | 0.00% | 0.0% |
| Q2 2023 | $5,276,022 | -34.5% | 244,600 | -11.0% | 0.00% | -33.3% |
| Q1 2023 | $8,059,698 | +69.4% | 274,700 | +113.3% | 0.00% | +50.0% |
| Q4 2022 | $4,759,160 | +0.0% | 128,800 | -23.8% | 0.00% | 0.0% |
| Q3 2022 | $4,757,000 | +983.6% | 169,000 | +641.2% | 0.00% | – |
| Q2 2022 | $439,000 | – | 22,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 78,800 | $2,311,992 | 0.01% |
| SIMPLEX TRADING, LLC | 189,300 | $5,554 | 0.01% |
| JANE STREET GROUP, LLC | 274,700 | $8,059,698 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |